Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Miller

Showing results (281-290 of 315) with videos related to

Pageof 32
Sort By:
The Journal of Urology|November 3, 2015
Age, Gender and R.E.N.A.L. Nephrometry Score do not Improve the Accuracy of a Risk Stratification Algorithm Based on Biopsy and Mass Size for Assigning Surveillance versus Treatment of Renal TumorsTakahiro Osawa, Khaled S Hafez, David C Miller, et al.
Urology|June 6, 2016
Comparison of Percutaneous Renal Mass Biopsy and R.E.N.A.L. Nephrometry Score Nomograms for Determining Benign Vs Malignant Disease and Low-risk Vs High-risk Renal TumorsTakahiro Osawa, Khaled S Hafez, David C Miller, et al.
The Journal of Urology|October 23, 2012
Understanding the use of immediate intravesical chemotherapy for patients with bladder cancerFrank N Burks, Alice B Liu, Ronald S Suh, et al.
Scientific Reports|January 22, 2021
Towards validation of combined-accelerated stress testing through failure analysis of polyamide-based photovoltaic backsheetsMichael Owen-Bellini, Stephanie L Moffitt, Archana Sinha, et al.
JAMA|June 27, 2013
Use of advanced treatment technologies among men at low risk of dying from prostate cancerBruce L Jacobs, Yun Zhang, Florian R Schroeck, et al.
Medical Care|November 8, 2016
Understanding Treatment Disconnect and Mortality Trends in Renal Cell Carcinoma Using Tumor Registry DataMarc C Smaldone, Brian Egleston, John M Hollingsworth, et al.
Contemporary Clinical Trials|October 21, 2021
Prostate cancer clinical trial completion: The role of geographyKristian D Stensland, Samuel D Kaffenberger, Arvin K George, et al.
Urology|April 22, 2018
Multi-institutional Survival Analysis of Incidental Pathologic T3a Upstaging in Clinical T1 Renal Cell Carcinoma Following Partial NephrectomyChristopher M Russell, Amir H Lebastchi, Juan Chipollini, et al.
The Journal of Urology|July 17, 2016
Appropriateness Criteria for Active Surveillance of Prostate CancerMichael L Cher, Apoorv Dhir, Gregory B Auffenberg, et al.
Cancer|October 21, 2017
Early effect of Medicare Shared Savings Program accountable care organization participation on prostate cancer careTudor Borza, Samuel R Kaufman, Phyllis Yan, et al.
Pageof 32

Showing results (281-290 of 315) with videos related to

Sort By:
Pageof 32
The Journal of Urology|November 3, 2015
Age, Gender and R.E.N.A.L. Nephrometry Score do not Improve the Accuracy of a Risk Stratification Algorithm Based on Biopsy and Mass Size for Assigning Surveillance versus Treatment of Renal TumorsTakahiro Osawa, Khaled S Hafez, David C Miller, et al.
Urology|June 6, 2016
Comparison of Percutaneous Renal Mass Biopsy and R.E.N.A.L. Nephrometry Score Nomograms for Determining Benign Vs Malignant Disease and Low-risk Vs High-risk Renal TumorsTakahiro Osawa, Khaled S Hafez, David C Miller, et al.
The Journal of Urology|October 23, 2012
Understanding the use of immediate intravesical chemotherapy for patients with bladder cancerFrank N Burks, Alice B Liu, Ronald S Suh, et al.
Scientific Reports|January 22, 2021
Towards validation of combined-accelerated stress testing through failure analysis of polyamide-based photovoltaic backsheetsMichael Owen-Bellini, Stephanie L Moffitt, Archana Sinha, et al.
JAMA|June 27, 2013
Use of advanced treatment technologies among men at low risk of dying from prostate cancerBruce L Jacobs, Yun Zhang, Florian R Schroeck, et al.
Medical Care|November 8, 2016
Understanding Treatment Disconnect and Mortality Trends in Renal Cell Carcinoma Using Tumor Registry DataMarc C Smaldone, Brian Egleston, John M Hollingsworth, et al.
Contemporary Clinical Trials|October 21, 2021
Prostate cancer clinical trial completion: The role of geographyKristian D Stensland, Samuel D Kaffenberger, Arvin K George, et al.
Urology|April 22, 2018
Multi-institutional Survival Analysis of Incidental Pathologic T3a Upstaging in Clinical T1 Renal Cell Carcinoma Following Partial NephrectomyChristopher M Russell, Amir H Lebastchi, Juan Chipollini, et al.
The Journal of Urology|July 17, 2016
Appropriateness Criteria for Active Surveillance of Prostate CancerMichael L Cher, Apoorv Dhir, Gregory B Auffenberg, et al.
Cancer|October 21, 2017
Early effect of Medicare Shared Savings Program accountable care organization participation on prostate cancer careTudor Borza, Samuel R Kaufman, Phyllis Yan, et al.
Pageof 32